Literature DB >> 15042288

Ventilator-associated pneumonia: caveats for benchmarking.

J E Tulleken, J G Zijlstra, J J M Ligtenberg, R Spanjersberg, T S van der Werf.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15042288     DOI： 10.1007/s00134-004-2247-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit.

Authors:  J J Parienti; M Ramakers; P Charbonneau
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

2.  Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.

Authors:  J Rello; M Sa-Borges; H Correa; S R Leal; J Baraibar
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

3.  Ventilator-associated pneumonia: caveats for benchmarking.

Authors:  Philippe Eggimann; Stéphane Hugonnet; Hugo Sax; Sylvie Touveneau; Jean-Claude Chevrolet; Didier Pittet
Journal:  Intensive Care Med       Date:  2003-09-03       Impact factor: 17.440
  3 in total
  1 in total

1.  Value and price of ventilator-associated pneumonia surveillance as a quality indicator.

Authors:  Heleen Aardema; L Marjon Dijkema; Mark G Lazonder; Jack Jm Ligtenberg; Jaap E Tulleken; Jan G Zijlstra
Journal:  Crit Care       Date:  2010-02-04       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.